'
• Introduction
o Ablation Equipments Overview
• Products under Development
o Ablation Equipments - Pipeline Products by Stage of Development
Table figure 1: Ablation Equipments - Pipeline Products by Stage of under Development
Table Ablation Equipments - Pipeline Products by Stage of under Development
o Ablation Equipments - Pipeline Products by Territory
Table figure 2: Ablation Equipments - Pipeline Products by Territory
Table Ablation Equipments - Pipeline Products by Territory
o Ablation Equipments - Pipeline Products by Regulatory Path
Table figure 3: Ablation Equipments - Pipeline Products by Regulatory Path
Table Ablation Equipments - Pipeline Products by Regulatory Path
o Ablation Equipments - Pipeline Products by Estimated Approval Date
Table figure 4: Ablation Equipments - Pipeline Products by Estimated Approval Date
Table Ablation Equipments - Pipeline Products by Estimated Approval Date
o Ablation Equipments - Ongoing Clinical Trials
Table figure 5: Ablation Equipments - Ongoing Clinical Trials
Table Ablation Equipments - Ongoing Clinical Trials
• Ablation Equipments - Pipeline Products under Development by Companies
o Ablation Equipments Companies - Pipeline Products by Stage of Development
Table Ablation Equipments Companies - Pipeline Products by Stage of Development
o Ablation Equipments - Pipeline Products by Stage of Development
Table Ablation Equipments - Pipeline Products by Stage of Development
• Ablation Equipments Companies and Product Overview
o AngioDynamics Inc Company Overview
AngioDynamics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table AngioDynamics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table NanoKnife Low Energy Direct Current System - Hepatocellular Carcinoma - Product Status
Table NanoKnife Low Energy Direct Current System - Hepatocellular Carcinoma - Product Description
Table NanoKnife System - Pancreatic Cancer - Product Status
Table NanoKnife System - Pancreatic Cancer - Product Description
Table NanoKnife System - Prostate Cancer - Product Status
Table NanoKnife System - Prostate Cancer - Product Description
Table Next Generation NanoKnife System - Product Status
Table Next Generation NanoKnife System - Product Description
Table AngioDynamics Inc - Ongoing Clinical Trials Overview
Table NanoKnife System - Prostate Cancer - Irreversible Electroporation(IRE) for Unresectable Prostatic Neoplasms: Phase I and Phase II Clinical Trial
Table NanoKnife System - Prostate Cancer - Multi-center Randomized Clinical Two Arm Intervention Study Evaluating Irreversible Electroporation for the Ablation of Localized Prostate Cancer
Table NanoKnife System - Pancreatic Cancer - A Clinical Research about Using Irreversible Electroporation to Treat Locally Advanced Pancreatic Cancer
Table NanoKnife System - Pancreatic Cancer - A Pilot Study of Irreversible Electroporation for the Treatment of Upfront Resectable Pancreatic Cancer in the Head of the Pancreas
Table NanoKnife System - Pancreatic Cancer - Evaluation of the Short and Intermediate Term Outcomes of Ablation of Locally Advanced Unresectable Pancreatic Cancer Using the NanoKnife Irreversible Electroporation (IRE) System - A Prospective Study
Table NanoKnife System - Pancreatic Cancer - Pilot-study: Non-thermal Ablation Using Irreversible Electroporation (IRE) to Treat Locally Advanced Pancreatic Carcinoma - A Phase I Clinical Trial – PANFIRE
Table NanoKnife Low Energy Direct Current System - Hepatocellular Carcinoma - A Prospective Clinical Trial Using Irreversible Electroporation (IRE) for the Treatment of Unresectable Hepatic Carcinoma Close to the Gallbladder
Table NanoKnife Low Energy Direct Current System - Hepatocellular Carcinoma - A Prospective Clinical Trial Using Irreversible Electroporation for the Treatment of Liver Cancers
Table NanoKnife Low Energy Direct Current System - Hepatocellular Carcinoma - Colorectal Metastatic Liver Disease: Efficacy of Irreversible Electroporation (IRE) - A Phase II Clinical Trial (COLDFIRE-2 Study)
Table NanoKnife Low Energy Direct Current System - Hepatocellular Carcinoma - Combination of Irreversible Electroporation and NK Immunotherapy for Recurrent Liver Cancer
Table NanoKnife Low Energy Direct Current System - Hepatocellular Carcinoma – Comparison Percutaneous Cryosurgery and Irreversible Electroportion in Unresectable Liver Cancer Close to Diaphragmatic Dome
Table NanoKnife Low Energy Direct Current System - Hepatocellular Carcinoma - Hepatic Carcinoma in Poor Liver Function: Safety and Efficacy of Irreversible Electroporation (IRE)
Table NanoKnife Low Energy Direct Current System - Hepatocellular Carcinoma – Irreversible Electroporation (IRE) for Unresectable Portal Venous Tumor Emboli: Phase I and Phase II Clinical Trial
Table Next Generation NanoKnife System - The Safety and Feasibility of Irreversible Electroporation for the Ablation of Small Renal Masses
o CPSI Biotech Company Overview
CPSI Biotech Pipeline Products & Ongoing Clinical Trials Overview
Table CPSI Biotech Pipeline Products & Ongoing Clinical Trials Overview
Table Pressurized Sub-Cooled Nitrogen System - Product Status
Table Pressurized Sub-Cooled Nitrogen System - Product Description
Table Super-Critical Nitrogen (SCN) Cryoablation Platform - Product Status
Table Super-Critical Nitrogen (SCN) Cryoablation Platform - Product Description
o Creo Medical Ltd. Company Overview
Creo Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview
Table Creo Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview
Table Flexible Ablation System - Product Status
Table Flexible Ablation System - Product Description
Table Lung Ablation Device - Product Status
Table Lung Ablation Device - Product Description
o Harmonic Medical Inc Company Overview
Harmonic Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table Harmonic Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table Symphony MRI guided High Intensity Focused Ultrasound - Leiomyomas - Product Status
Table Symphony MRI guided High Intensity Focused Ultrasound - Leiomyomas - Product Description
Table Harmonic Medical Inc - Ongoing Clinical Trials Overview
Table Symphony MRI guided High Intensity Focused Ultrasound - Leiomyomas - MRI-guided High Intensity Focused Ultrasound Ablation of Leiomyomas. Single Arm, Feasibility Study Using the Symphony - MRI Guided Focused Ultrasound System for the Treatment of Leiomyomas.
o HistoSonics Inc Company Overview
HistoSonics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table HistoSonics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table Vortx RX - Product Status
Table Vortx RX - Product Description
Table HistoSonics Inc - Ongoing Clinical Trials Overview
Table Vortx RX - Safety and Initial Efficacy Study of the Vortx Rx for Treatment of Benign Prostatic Hyperplasia (US)
o Hospital for Special Surgery Company Overview
Hospital for Special Surgery Pipeline Products & Ongoing Clinical Trials Overview
Table Hospital for Special Surgery Pipeline Products & Ongoing Clinical Trials Overview
Table Radiofrequency Ablation Device - Product Status
Table Radiofrequency Ablation Device - Product Description
o Imricor Medical Systems Inc Company Overview
Imricor Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
Table Imricor Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
Table Vision MR Ablation Catheter - Product Status
Table Vision MR Ablation Catheter - Product Description
Table Imricor Medical Systems Inc - Ongoing Clinical Trials Overview
Table Vision MR Ablation Catheter - Cardiovascular Magnetic Resonance-guided Radiofrequency- Ablation for Atrial Flutter
Table Vision MR Ablation Catheter - Evaluation of MR-enabled Systems in the Treatment of Atrial Flutter: A Prospective Pilot Study
o Innoblative Designs, Inc. Company Overview
Innoblative Designs, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table Innoblative Designs, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table RFA Applicator - Product Status
Table RFA Applicator - Product Description
o Integra LifeSciences Holdings Corp Company Overview
Integra LifeSciences Holdings Corp Pipeline Products & Ongoing Clinical Trials Overview
Table Integra LifeSciences Holdings Corp Pipeline Products & Ongoing Clinical Trials Overview
Table CUSA Ultrasonic Tissue Ablation System - Liver - Product Status
Table CUSA Ultrasonic Tissue Ablation System - Liver - Product Description
o Intratherm, Llc Company Overview
Intratherm, Llc Pipeline Products & Ongoing Clinical Trials Overview
Table Intratherm, Llc Pipeline Products & Ongoing Clinical Trials Overview
Table CITT Device - Product Status
Table CITT Device - Product Description
o Medtronic plc Company Overview
Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
Table Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
Table Barrx 360 Express RFA Balloon Catheter - Product Status
Table Barrx 360 Express RFA Balloon Catheter - Product Description
Table Nerve Cryoablation System - Product Status
Table Nerve Cryoablation System - Product Description
o Memorial Sloan Kettering Cancer Center Company Overview
Memorial Sloan Kettering Cancer Center Pipeline Products & Ongoing Clinical Trials Overview
Table Memorial Sloan Kettering Cancer Center Pipeline Products & Ongoing Clinical Trials Overview
Table Image-Guided Ablation Device - Product Status
Table Image-Guided Ablation Device - Product Description
o Mirabilis Medical Inc Company Overview
Mirabilis Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table Mirabilis Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table Mirabilis System - Product Status
Table Mirabilis System - Product Description
Table Mirabilis Medical Inc - Ongoing Clinical Trials Overview
Table Mirabilis System - Directed Ablation of Uterine Fibroids Using a Noninvasive Approach: DIANA
o Prosurg Inc Company Overview
Prosurg Inc Pipeline Products & Ongoing Clinical Trials Overview
Table Prosurg Inc Pipeline Products & Ongoing Clinical Trials Overview
Table ImaGel - Product Status
Table ImaGel - Product Description
o Pulse Biosciences, Inc. Company Overview
Pulse Biosciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table Pulse Biosciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table PulseTx System - Seborrheic Keratosis - Product Status
Table PulseTx System - Seborrheic Keratosis - Product Description
Table PulseTx System - Soft Tissue Ablation - Product Status
Table PulseTx System - Soft Tissue Ablation - Product Description
Table Pulse Biosciences, Inc. - Ongoing Clinical Trials Overview
Table PulseTx System - Soft Tissue Ablation - First-of-its-kind PulseTx System in Pilot Study in Dermatology
Table PulseTx System - Seborrheic Keratosis - Clinical Evaluation of Safety and Efficacy of Nano-pulse Stimulation Technology for Seborrheic Keratosis Lesions
o Southern Illinois University Carbondale Company Overview
Southern Illinois University Carbondale Pipeline Products & Ongoing Clinical Trials Overview
Table Southern Illinois University Carbondale Pipeline Products & Ongoing Clinical Trials Overview
Table Thermoablation Probe - Product Status
Table Thermoablation Probe - Product Description
o Thermedical Inc Company Overview
Thermedical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table Thermedical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table SERF Ablation System - Fibroids - Product Status
Table SERF Ablation System - Fibroids - Product Description
o TransEnterix, Inc. Company Overview
TransEnterix, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table TransEnterix, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table Barrett's Excision Device - Product Status
Table Barrett's Excision Device - Product Description
o University of California San Francisco Company Overview
University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview
Table University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview
Table Robotic Needle Ablation Tool And Securement Device - Product Status
Table Robotic Needle Ablation Tool And Securement Device - Product Description
o University of Texas at Austin Company Overview
University of Texas at Austin Pipeline Products & Ongoing Clinical Trials Overview
Table University of Texas at Austin Pipeline Products & Ongoing Clinical Trials Overview
Table Plasmonic Laser Ablation Device - Product Status
Table Plasmonic Laser Ablation Device - Product Description
o University of Wisconsin-Stout Company Overview
University of Wisconsin-Stout Pipeline Products & Ongoing Clinical Trials Overview
Table University of Wisconsin-Stout Pipeline Products & Ongoing Clinical Trials Overview
Table Microwave Ablation Probe - Product Status
Table Microwave Ablation Probe - Product Description
• Ablation Equipments- Recent Developments
o Dec 12, 2017: Stryker announces Mr. Howard E. Cox, Jr. will retire from Board of Directors
o Nov 21, 2017: Medtronic Reports Second Quarter Financial Results
o Nov 08, 2017: Medtronic Announces Preliminary Second Quarter Revenue
o Nov 07, 2017: Misonix Reports First Quarter Fiscal Year 2018 Financial Results
o Nov 06, 2017: Ethicon Celebrates 130 Years of Transforming Surgery to Advance Patient Outcomes
o Nov 03, 2017: Smith & Nephew Third Quarter 2017 Trading Report
o Nov 02, 2017: Medtronic Releases Fiscal Year 2017 Integrated Performance Report
o Nov 01, 2017: AtriCure Reports Third Quarter 2017 Financial Results
o Oct 26, 2017: Stryker reports third quarter 2017 results
o Oct 26, 2017: Integra LifeSciences Reports Third Quarter 2017 Financial Results
o Oct 25, 2017: Baylis Medical's Kris Shah appointed to AdvaMed Accel Board of Directors
o Oct 19, 2017: CLS signs supplier agreement with University of Texas Medical Branch and receives the first order
o Oct 18, 2017: Relievant Medsystems Names Ray M. Baker, M.D. as Chief Medical Officer
o Oct 09, 2017: Smith & Nephew: Notice of Chief Executive Officer's intention to retire by end of 2018
o Oct 09, 2017: Notice of Chief Executive Officer's intention to retire by end of 2018
o Oct 06, 2017: Medtronic Provides Update on Impact from Hurricane Maria
o Oct 02, 2017: Smith & Nephew Announces Directorate Change
o Sep 28, 2017: AngioDynamics Reports Fiscal 2018 First Quarter Results
o Sep 26, 2017: Integra LifeSciences Provides Preliminary Assessment of Minor Damage to its Manufacturing Facility in Anasco, Puerto Rico
o Sep 20, 2017: SonaCare Medical Reports that CMS Announces Increase to ASC Payment for HIFU Prostate Ablation
o Sep 19, 2017: Relievant Medsystems Names Kevin Hykes Chief Executive Officer
o Sep 19, 2017: HistoSonics Expands Leadership Team As It Accelerates Growth
o Sep 18, 2017: Smith & Nephew Announces Change in Board of Directors
o Sep 12, 2017: Smith & Nephew: Appointment of Marc Owen as Non-Executive Director
o Sep 11, 2017: Pulse Biosciences Announces Withdrawal and Planned Resubmission of 510(k) Application for the PulseTx System
o Aug 23, 2017: Misonix Appoints Joseph Dwyer as Chief Financial Officer
o Aug 23, 2017: Baylis Medical strengthens global expansion plans with senior hire
o Aug 22, 2017: Misonix Reports Fiscal Year 2017 Financial Results
o Aug 22, 2017: Medtronic Reports First Quarter Financial Results
o Aug 09, 2017: Novadaq Receives Court Approval for Arrangement With Stryker
o Aug 02, 2017: Stryker announces election of new Director, Mary K. Brainerd
o Jul 27, 2017: Smith & Nephew Second Quarter and First Half 2017 Results
o Jul 27, 2017: Stryker reports second quarter 2017 results
o Jul 27, 2017: AtriCure Reports Second Quarter 2017 Financial Results
o Jul 26, 2017: Integra LifeSciences Reports Second Quarter 2017 Financial Results
o Jul 18, 2017: AngioDynamics Reports Fiscal 2017 Fourth Quarter and Full-Year Results
o Jul 18, 2017: AtriCure Announces Hiring of Chief Technology Officer
o Jul 04, 2017: Appointment of Angie Risley as Non-Executive Director and Chairman Elect of the Remuneration Committee
o Jun 29, 2017: FDA Confirms 510(K) Submission Pathway For Creo's Flexible Ablation System
o Jun 19, 2017: CSA Medical Appoints Jean Bjerke, Vice President of Marketing
o Jun 07, 2017: AngioDynamics Announces FDA Clearance for The Solero Microwave Tissue Ablation System
o Jun 07, 2017: HistoSonics Announces Addition to Management Team
o Jun 06, 2017: Pulse Biosciences Announces Treatment of First Patient in Study to Evaluate the Safety and Efficacy of Novel Nano-Pulse Stimulation Technology for Seborrheic Keratosis Lesions
o May 25, 2017: Medtronic Reports Fourth Quarter and Fiscal Year 2017 Financial Results
o May 17, 2017: Syneron Medical Reports First Quarter 2017 Revenue of $66.9 Million
o May 12, 2017: Smith & Nephew opens state-of-the-art Research & Development Centre
o May 10, 2017: The Centers for Disease Control and Prevention Updated Guideline Now Include a Recommendation for Triclosan-Coated Sutures
o May 05, 2017: Smith & Nephew 2017 First Quarter Trading Report
o May 04, 2017: AtriCure Reports First Quarter 2017 Financial Results
o May 04, 2017: Olympus Extends Portfolio of EndoTherapy Solutions at DDW
o May 02, 2017: Misonix Reports Third Quarter Fiscal Year 2017 Financial Results
o Apr 26, 2017: Integra LifeSciences Reports First Quarter 2017 Financial Results
o Apr 25, 2017: Stryker reports first quarter 2017 results
o Apr 20, 2017: Key Appointment to Board of Directors at Cianna Medical
o Mar 30, 2017: AngioDynamics Reports Fiscal 2017 Third Quarter Results
o Mar 23, 2017: Mirabilis Medical Announces European Approval for Non-Invasive Uterine Fibroid Treatment
o Mar 23, 2017: Mirabilis receives FDA approval for US clinical study
o Mar 14, 2017: Pulse Biosciences Submits 510(k) Application to FDA for PulseTx System
o Mar 14, 2017: AngioDynamics Receives CE Mark Certification for The Solero Microwave Tissue Ablation System
o Mar 13, 2017: Misonix Announces Second Quarters of Fiscal 2017
o Mar 13, 2017: HistoSonics Appoints Mike Blue as CEO and Board Member
o Mar 13, 2017: Misonix Files Forms 10-Q for First and Second Quarters of Fiscal 2017
o Mar 06, 2017: AtriCure Announces hiring of Senior Vice President of Clinical, Regulatory, and Scientific Affairs
o Mar 06, 2017: TransEnterix Reports Operating Results for the Fourth Quarter and Full Year 2016
o Feb 28, 2017: AtriCure Reports Fourth Quarter and Full Year 2016 Financial Results
o Feb 23, 2017: Integra LifeSciences Reports Fourth Quarter and Full-Year 2016 Financial Results and Updates 2017 Full-Year Guidance
o Feb 21, 2017: Medtronic Reports Third Quarter Financial Results
o Feb 15, 2017: Syneron Medical Reports Fourth Quarter 2016 Revenue of $82.9 Million and Full Year 2016 Revenue $298.1 Million
o Feb 09, 2017: Smith & Nephew Fourth Quarter Trading and Full Year 2016 Results
o Feb 09, 2017: Smith & Nephew: Directorate Change
o Feb 06, 2017: Medtronic Awarded U.S. Department of Veterans Affairs National Contracts for Home Telehealth Technologies, with Three Other Vendors
o Jan 31, 2017: Syneron Medical Strengthens Senior Management Team with Appointment of Chief Human Resources Officer
o Jan 24, 2017: Stryker reports 2016 results and 2017 outlook
o Jan 17, 2017: Aurora Cancer Care is first in Wisconsin to perform new Nanoknife therapy technique to treat pancreatic and liver cancers
o Jan 12, 2017: Confirmation of CFO leaving Smith & Nephew
o Jan 10, 2017: Stryker provides 2016 preliminary net sales results
o Jan 09, 2017: AtriCure Announces Preliminary Results for Fourth Quarter and Full Year 2016
o Jan 06, 2017: AngioDynamics Reports Fiscal 2017 Second Quarter Results
o Dec 19, 2016: Stavros G. Vizirgianakis Appointed President and CEO of Misonix
• Appendix
o Methodology
